| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 3 | 308.8 | 49.5 | 1 | - | - | 362.2 |
| - | - | - | - | 2.3 | 237.8 | 180.5 | 11 | - | - | 431.6 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 4 |
| 1.5 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 1,443 | 95.0% | 0.23 | 1,691 | 99.2% |
| Optic-unspecified(L) | 60 | 3.9% | -2.91 | 8 | 0.5% |
| AME(L) | 16 | 1.1% | -1.42 | 6 | 0.4% |
| upstream partner | # | NT | conns Cm25 | % In | CV |
|---|---|---|---|---|---|
| Dm2 (L) | 124 | ACh | 68.8 | 18.7% | 0.8 |
| MeVPMe5 (R) | 7 | Glu | 52.5 | 14.3% | 0.9 |
| MeTu1 (L) | 50 | ACh | 45.8 | 12.5% | 0.7 |
| MeVC5 (R) | 1 | ACh | 21.5 | 5.9% | 0.0 |
| MeVC8 (R) | 1 | ACh | 17 | 4.6% | 0.0 |
| Cm25 (L) | 4 | Glu | 14.2 | 3.9% | 0.2 |
| MeVPMe9 (R) | 4 | Glu | 11 | 3.0% | 0.9 |
| MeVC2 (R) | 1 | ACh | 7.8 | 2.1% | 0.0 |
| MeVC9 (R) | 1 | ACh | 7.2 | 2.0% | 0.0 |
| MeVPMe8 (L) | 1 | Glu | 6.5 | 1.8% | 0.0 |
| Cm23 (L) | 6 | Glu | 6.2 | 1.7% | 0.6 |
| aMe4 (L) | 6 | ACh | 6 | 1.6% | 0.4 |
| MeVC27 (R) | 3 | unc | 5.8 | 1.6% | 0.3 |
| Cm4 (L) | 7 | Glu | 4.8 | 1.3% | 0.4 |
| MeLo6 (L) | 8 | ACh | 4.5 | 1.2% | 0.5 |
| Cm12 (L) | 11 | GABA | 4.5 | 1.2% | 0.4 |
| Cm34 (L) | 1 | Glu | 4 | 1.1% | 0.0 |
| MeTu3b (L) | 7 | ACh | 4 | 1.1% | 0.5 |
| MeVP6 (L) | 11 | Glu | 4 | 1.1% | 0.5 |
| Cm5 (L) | 12 | GABA | 4 | 1.1% | 0.4 |
| Mi15 (L) | 13 | ACh | 3.8 | 1.0% | 0.3 |
| OA-AL2i4 (L) | 1 | OA | 3.5 | 1.0% | 0.0 |
| TmY17 (L) | 7 | ACh | 3.2 | 0.9% | 0.4 |
| Cm16 (L) | 9 | Glu | 3.2 | 0.9% | 0.3 |
| MeVP7 (L) | 7 | ACh | 3 | 0.8% | 0.3 |
| MeTu3c (L) | 9 | ACh | 3 | 0.8% | 0.4 |
| Cm9 (L) | 7 | Glu | 2.5 | 0.7% | 0.5 |
| Tm38 (L) | 7 | ACh | 2.2 | 0.6% | 0.4 |
| MeVC7a (R) | 1 | ACh | 2 | 0.5% | 0.0 |
| Cm21 (L) | 6 | GABA | 2 | 0.5% | 0.6 |
| Cm6 (L) | 6 | GABA | 1.8 | 0.5% | 0.3 |
| aMe5 (L) | 6 | ACh | 1.8 | 0.5% | 0.3 |
| Cm3 (L) | 6 | GABA | 1.8 | 0.5% | 0.3 |
| Cm8 (L) | 7 | GABA | 1.8 | 0.5% | 0.0 |
| Cm24 (L) | 3 | Glu | 1.5 | 0.4% | 0.4 |
| Cm30 (L) | 2 | GABA | 1.5 | 0.4% | 0.7 |
| MeVPMe11 (R) | 1 | Glu | 1.5 | 0.4% | 0.0 |
| TmY10 (L) | 2 | ACh | 1.2 | 0.3% | 0.6 |
| Mi10 (L) | 3 | ACh | 1.2 | 0.3% | 0.3 |
| Cm14 (L) | 5 | GABA | 1.2 | 0.3% | 0.0 |
| MeVC6 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| aMe26 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| MeVC20 (L) | 2 | Glu | 1 | 0.3% | 0.5 |
| MeVP9 (L) | 1 | ACh | 0.8 | 0.2% | 0.0 |
| aMe10 (L) | 1 | ACh | 0.8 | 0.2% | 0.0 |
| MeVPMe10 (R) | 1 | Glu | 0.8 | 0.2% | 0.0 |
| MeVP29 (L) | 1 | ACh | 0.8 | 0.2% | 0.0 |
| MeTu4a (L) | 3 | ACh | 0.8 | 0.2% | 0.0 |
| MeVP59 (L) | 1 | ACh | 0.8 | 0.2% | 0.0 |
| Cm35 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| MeVC3 (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVC22 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| Mi1 (L) | 2 | ACh | 0.5 | 0.1% | 0.0 |
| MeLo5 (L) | 2 | ACh | 0.5 | 0.1% | 0.0 |
| MeVP12 (L) | 2 | ACh | 0.5 | 0.1% | 0.0 |
| MeVP32 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVP45 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| aMe17e (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 0.5 | 0.1% | 0.0 |
| Cm18 (L) | 2 | Glu | 0.5 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| aMe12 (L) | 2 | ACh | 0.5 | 0.1% | 0.0 |
| MeTu4d (L) | 2 | ACh | 0.5 | 0.1% | 0.0 |
| Tm34 (L) | 2 | Glu | 0.5 | 0.1% | 0.0 |
| MeVP1 (L) | 2 | ACh | 0.5 | 0.1% | 0.0 |
| Dm-DRA1 (L) | 2 | Glu | 0.5 | 0.1% | 0.0 |
| Cm17 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| Tm5c (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 0.2 | 0.1% | 0.0 |
| MeVC23 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Tm16 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Mi14 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Cm22 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| MeTu4b (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeLo3b (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Cm28 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVC24 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVP11 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP21 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Tm37 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeTu2b (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Lat3 (L) | 1 | unc | 0.2 | 0.1% | 0.0 |
| TmY21 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeTu3a (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Cm20 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| ME_unclear (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVP34 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| aMe30 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeTu4c (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Cm1 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP14 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP20 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Cm10 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| MeVP42 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| downstream partner | # | NT | conns Cm25 | % Out | CV |
|---|---|---|---|---|---|
| Cm8 (L) | 43 | GABA | 168 | 14.0% | 0.8 |
| Cm12 (L) | 17 | GABA | 159 | 13.3% | 1.0 |
| Cm3 (L) | 40 | GABA | 103.8 | 8.7% | 0.9 |
| Cm5 (L) | 33 | GABA | 86.2 | 7.2% | 0.8 |
| Cm14 (L) | 11 | GABA | 70 | 5.9% | 0.8 |
| Cm16 (L) | 11 | Glu | 33.5 | 2.8% | 1.0 |
| MeTu3b (L) | 8 | ACh | 32 | 2.7% | 0.9 |
| MeTu4c (L) | 17 | ACh | 30 | 2.5% | 0.9 |
| MeLo6 (L) | 12 | ACh | 29.2 | 2.4% | 1.1 |
| MeTu4f (L) | 9 | ACh | 27.5 | 2.3% | 0.8 |
| MeTu4a (L) | 8 | ACh | 25 | 2.1% | 1.5 |
| Cm10 (L) | 26 | GABA | 23.8 | 2.0% | 0.5 |
| Cm34 (L) | 1 | Glu | 20.2 | 1.7% | 0.0 |
| Tm26 (L) | 19 | ACh | 20.2 | 1.7% | 0.6 |
| MeLo5 (L) | 10 | ACh | 20 | 1.7% | 0.8 |
| Tm16 (L) | 25 | ACh | 19.2 | 1.6% | 0.7 |
| MeTu4d (L) | 7 | ACh | 14.5 | 1.2% | 0.8 |
| Cm25 (L) | 4 | Glu | 14.2 | 1.2% | 0.2 |
| MeTu1 (L) | 21 | ACh | 14 | 1.2% | 1.2 |
| TmY18 (L) | 16 | ACh | 12.8 | 1.1% | 0.6 |
| MeVP7 (L) | 3 | ACh | 12 | 1.0% | 0.7 |
| ME_unclear (L) | 3 | Glu | 10.8 | 0.9% | 0.7 |
| Cm20 (L) | 4 | GABA | 10 | 0.8% | 1.3 |
| MeTu3c (L) | 11 | ACh | 10 | 0.8% | 0.7 |
| Mi15 (L) | 29 | ACh | 9.8 | 0.8% | 0.4 |
| Tm34 (L) | 9 | Glu | 8.2 | 0.7% | 1.0 |
| TmY10 (L) | 19 | ACh | 8 | 0.7% | 0.5 |
| TmY21 (L) | 11 | ACh | 7.2 | 0.6% | 0.5 |
| Tm35 (L) | 7 | Glu | 7.2 | 0.6% | 0.7 |
| Tm36 (L) | 10 | ACh | 7 | 0.6% | 0.6 |
| MeVPMe8 (L) | 2 | Glu | 6.8 | 0.6% | 0.0 |
| MeVP8 (L) | 4 | ACh | 6 | 0.5% | 1.0 |
| Mi16 (L) | 6 | GABA | 6 | 0.5% | 0.7 |
| Tm37 (L) | 10 | Glu | 5.8 | 0.5% | 0.7 |
| aMe9 (L) | 2 | ACh | 5.5 | 0.5% | 0.1 |
| Cm35 (L) | 1 | GABA | 5 | 0.4% | 0.0 |
| Pm13 (L) | 1 | Glu | 4.5 | 0.4% | 0.0 |
| T2 (L) | 14 | ACh | 4.5 | 0.4% | 0.6 |
| Cm9 (L) | 11 | Glu | 4.2 | 0.4% | 0.7 |
| MeVPMe5 (L) | 2 | Glu | 4 | 0.3% | 0.9 |
| Cm7 (L) | 6 | Glu | 4 | 0.3% | 0.6 |
| Cm17 (L) | 5 | GABA | 3.8 | 0.3% | 1.3 |
| Cm6 (L) | 10 | GABA | 3.8 | 0.3% | 0.3 |
| Cm21 (L) | 5 | GABA | 3.5 | 0.3% | 0.8 |
| Cm30 (L) | 2 | GABA | 3.2 | 0.3% | 0.8 |
| Mi17 (L) | 5 | GABA | 3.2 | 0.3% | 0.4 |
| MeVP6 (L) | 6 | Glu | 3.2 | 0.3% | 0.6 |
| Dm8a (L) | 2 | Glu | 3 | 0.3% | 0.8 |
| aMe4 (L) | 5 | ACh | 3 | 0.3% | 0.6 |
| Tm33 (L) | 8 | ACh | 2.8 | 0.2% | 0.4 |
| T2a (L) | 8 | ACh | 2.8 | 0.2% | 0.4 |
| MeVP2 (L) | 4 | ACh | 2.5 | 0.2% | 0.6 |
| Cm33 (L) | 1 | GABA | 2.2 | 0.2% | 0.0 |
| MeVP21 (L) | 2 | ACh | 2.2 | 0.2% | 0.8 |
| MeVP14 (L) | 3 | ACh | 2.2 | 0.2% | 0.3 |
| Dm2 (L) | 5 | ACh | 2.2 | 0.2% | 0.4 |
| MeVPLo1 (L) | 2 | Glu | 2 | 0.2% | 0.2 |
| TmY9a (L) | 4 | ACh | 2 | 0.2% | 0.5 |
| MeVP9 (L) | 3 | ACh | 2 | 0.2% | 0.6 |
| Mi18 (L) | 6 | GABA | 2 | 0.2% | 0.4 |
| Tm38 (L) | 3 | ACh | 1.8 | 0.1% | 0.5 |
| Mi9 (L) | 5 | Glu | 1.8 | 0.1% | 0.6 |
| TmY4 (L) | 4 | ACh | 1.8 | 0.1% | 0.5 |
| Cm23 (L) | 4 | Glu | 1.8 | 0.1% | 0.2 |
| Tm5c (L) | 7 | Glu | 1.8 | 0.1% | 0.0 |
| Tm40 (L) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| MeVP33 (L) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| Tm5a (L) | 4 | ACh | 1.5 | 0.1% | 0.3 |
| MeVP55 (L) | 2 | Glu | 1.5 | 0.1% | 0.3 |
| TmY9b (L) | 3 | ACh | 1.5 | 0.1% | 0.0 |
| Pm12 (L) | 2 | GABA | 1.5 | 0.1% | 0.3 |
| TmY17 (L) | 1 | ACh | 1.2 | 0.1% | 0.0 |
| MeVP43 (L) | 1 | ACh | 1.2 | 0.1% | 0.0 |
| MeTu4e (L) | 3 | ACh | 1.2 | 0.1% | 0.3 |
| Y14 (L) | 3 | Glu | 1.2 | 0.1% | 0.3 |
| MeVP59 (L) | 2 | ACh | 1.2 | 0.1% | 0.6 |
| MeVPMe12 (L) | 2 | ACh | 1.2 | 0.1% | 0.6 |
| Tm4 (L) | 4 | ACh | 1.2 | 0.1% | 0.3 |
| Dm-DRA1 (L) | 2 | Glu | 1.2 | 0.1% | 0.2 |
| Tm30 (L) | 3 | GABA | 1 | 0.1% | 0.4 |
| Mi1 (L) | 3 | ACh | 1 | 0.1% | 0.4 |
| Tm31 (L) | 2 | GABA | 1 | 0.1% | 0.5 |
| MeLo7 (L) | 3 | ACh | 1 | 0.1% | 0.4 |
| Tm2 (L) | 3 | ACh | 1 | 0.1% | 0.4 |
| aMe17a (L) | 1 | unc | 1 | 0.1% | 0.0 |
| MeTu2b (L) | 3 | ACh | 1 | 0.1% | 0.4 |
| Mi4 (L) | 4 | GABA | 1 | 0.1% | 0.0 |
| Tm5b (L) | 4 | ACh | 1 | 0.1% | 0.0 |
| LPi4a (L) | 1 | Glu | 0.8 | 0.1% | 0.0 |
| Cm11b (L) | 1 | ACh | 0.8 | 0.1% | 0.0 |
| Tm29 (L) | 2 | Glu | 0.8 | 0.1% | 0.3 |
| MeVC27 (R) | 2 | unc | 0.8 | 0.1% | 0.3 |
| Mi19 (L) | 2 | unc | 0.8 | 0.1% | 0.3 |
| MeVP12 (L) | 1 | ACh | 0.8 | 0.1% | 0.0 |
| MeVP58 (L) | 1 | Glu | 0.8 | 0.1% | 0.0 |
| MeVPMe9 (R) | 2 | Glu | 0.8 | 0.1% | 0.3 |
| MeVP29 (L) | 1 | ACh | 0.8 | 0.1% | 0.0 |
| Lawf1 (L) | 2 | ACh | 0.8 | 0.1% | 0.3 |
| Cm1 (L) | 2 | ACh | 0.8 | 0.1% | 0.3 |
| Tm20 (L) | 1 | ACh | 0.8 | 0.1% | 0.0 |
| Cm11c (L) | 2 | ACh | 0.8 | 0.1% | 0.3 |
| MeLo1 (L) | 2 | ACh | 0.8 | 0.1% | 0.3 |
| MeVPMe6 (L) | 1 | Glu | 0.8 | 0.1% | 0.0 |
| Pm4 (L) | 2 | GABA | 0.8 | 0.1% | 0.3 |
| MeTu4b (L) | 2 | ACh | 0.8 | 0.1% | 0.3 |
| Tm39 (L) | 3 | ACh | 0.8 | 0.1% | 0.0 |
| MeVP32 (L) | 1 | ACh | 0.8 | 0.1% | 0.0 |
| Tm3 (L) | 3 | ACh | 0.8 | 0.1% | 0.0 |
| Cm24 (L) | 2 | Glu | 0.8 | 0.1% | 0.3 |
| MeVP11 (L) | 2 | ACh | 0.8 | 0.1% | 0.3 |
| MeVC22 (L) | 2 | Glu | 0.8 | 0.1% | 0.3 |
| Lat3 (L) | 3 | unc | 0.8 | 0.1% | 0.0 |
| Tm1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Tm5Y (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP46 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm2 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVC2 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP48 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC25 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm18 (L) | 2 | Glu | 0.5 | 0.0% | 0.0 |
| TmY3 (L) | 2 | ACh | 0.5 | 0.0% | 0.0 |
| Tm12 (L) | 2 | ACh | 0.5 | 0.0% | 0.0 |
| MeVPMe5 (R) | 2 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe17e (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 0.5 | 0.0% | 0.0 |
| MeVP49 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| C2 (L) | 2 | GABA | 0.5 | 0.0% | 0.0 |
| C3 (L) | 2 | GABA | 0.5 | 0.0% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP45 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm31b (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Tm9 (L) | 2 | ACh | 0.5 | 0.0% | 0.0 |
| aMe12 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeTu2a (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeVP61 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| aMe3 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| MeVC20 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Cm13 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Tm32 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| TmY20 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Cm28 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| MeVC10 (R) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeVC7b (R) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 0.2 | 0.0% | 0.0 |
| Mi14 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Cm15 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| TmY5a (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| MeVP10 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| TmY14 (L) | 1 | unc | 0.2 | 0.0% | 0.0 |
| OA-ASM1 (R) | 1 | OA | 0.2 | 0.0% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Cm31a (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| aMe17c (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| MeVP15 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeLo3b (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Mi13 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Cm22 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| Tm_unclear (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeVP_unclear (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Cm11d (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeVP40 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 0.2 | 0.0% | 0.0 |